Missing periods in replicate designs [RSABE / ABEL]

posted by d_labes  – Berlin, Germany, 2019-10-18 11:48 (459 d 13:50 ago) – Posting: # 20703
Views: 5,841

Dear ElMaestro,

» ...
» §4.8.3: Neither the investigator, nor the trial staff, should coerce or unduly influence a subject to participate or to continue to participate in a trial.

Was of course not an unduly influence. Only a friendly talk by phone to obtain some informations about the reasons and circumstances of refusing the continuation.

Regards,

Detlew

Complete thread:

Activity
 Admin contact
21,306 posts in 4,443 threads, 1,488 registered users;
online 4 (0 registered, 4 guests [including 2 identified bots]).
Forum time: Wednesday 00:39 CET (Europe/Vienna)

Power: That which is wielded by the priesthood of
clinical trials, the statisticians, and a stick which they use
to beta their colleagues.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5